• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

TML-6

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5798113

TML-6, an orally active curcumin derivative, inhibits the synthesis of the beta-amyloid precursor protein and beta-amyloid (Abeta). TML-6 can upregulate Apo E, suppress NF-kappaB and mTOR, and increase the activity of the anti-oxidative Nrf2 gene. TML-6 has… More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
TML-6, Biochemical
Full Product Name
TML-6
Product Gene Name
Purity/Purification
98%
Preparation and Storage
Powder: -20 degree C for 3 years
In solvent: -80 degree C for 2 years
Formula
C30H37NO7
CAS
1462868-88-7
Solubility
DMSO: 120 mg/mL (229.17 mM),
Need ultrasonic
<1mg/ml refers to the product slightly soluble or insoluble
In vitro
TML-6 (diet; 150 mg/kg/day; for four months) treatment results in significant improvement in learning, suppression of the microglial activation marker Iba-1, and reduction in Abeta in the brain[1]. TML-6 (oral; 150 mg/kg) has a T1/2 of 1.27 hours, a Cmax of 35.9 ng/mL and an AUC of 177 ng/hr/mL[1].

Other Notes

Small volumes of TML-6 biochemical vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for TML-6 purchase

MBS5798113 is a biochemical targeting TML-6.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000